![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication July 24, 2006.
Revised October 29, 2006.
Accepted for publication November 15, 2006.
, Rho and myosin phosphatase in vascular smooth muscle
We have recently demonstrated in vascular smooth muscle (VSM) that membrane depolarization by high KCl induces Ca2+-dependent Rho activation and myosin phosphatase (MLCP) inhibition (Ca2+-induced Ca2+-sensitization) through the mechanisms involving phosphorylation of MYPT1 and CPI-17. In the present study, we investigated whether and how cyclic AMP affected Ca2+-dependent MLCP inhibiton by examining the effects of forskolin, cell permeable dibutyryl cyclic AMP (dbcAMP) and isoproterenol. Forskolin, but not its inactive analogue 1,9-dideoxyforskolin, inhibited KCl-induced contraction and the 20 kDa myosin light chain (MLC) phosphorylation without inhibiting Ca2+ mobilization in rabbit aortic VSM. DbcAMP mimicked these forskolin effects. We recently suggested that Ca2+-mediated Rho activation is dependent on class II
-isoform of phosphoinositide 3-kinase (PI3K-C2
). Forskolin inhibited KCl-induced stimulation of PI3K-C2
activity. KCl-induced membrane depolarization stimulated Rho in a manner dependent on a PI3K but not PKC (protein kinase C), and stimulated phosphorylation of MYPT1 at Thr850 and CPI-17 at Thr38 in manners dependent on both PI3K and Rho-kinase, but not PKC. Forskolin, dbcAMP and isoproterenol inhibited KCl-induced Rho activation and phosphorylation of MYPT1 and CPI-17. Consistent with these data, either forskolin, isoproterenol, a PI3K inhibitor, or a Rho kinase inhibitor, but not a PKC inhibitor, abolished KCl-induced di-phosphorylation of MLC. These observations indicate that cyclic AMP inhibits Ca2+-mediated activation of the MLCP-regulating signaling pathway comprising PI3K-C2
, Rho, and Rho kinase in a manner independent of Ca2+, and point to the novel mechanism of the cyclic AMP actions in the regulation of vascular smooth muscle contraction.
Key words:
Calcium, Rho, Vascular smooth muscle, cyclic AMP, myosin phosphatase, phosphoinositide 3-kinase
This article has been cited by other articles:
![]() |
Y. M. Seok, I. Baek, Y.-H. Kim, Y.-S. Jeong, I.-J. Lee, D. H. Shin, Y. H. Hwang, and I. K. Kim Isoflavone Attenuates Vascular Contraction through Inhibition of the RhoA/Rho-Kinase Signaling Pathway J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 991 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schaafsma, K. D. McNeill, G. L. Stelmack, R. Gosens, H. A. Baarsma, B. G. J. Dekkers, E. Frohwerk, J.-M. Penninks, P. Sharma, K. M. Ens, et al. Insulin increases the expression of contractile phenotypic markers in airway smooth muscle Am J Physiol Cell Physiol, July 1, 2007; 293(1): C429 - C439. [Abstract] [Full Text] [PDF] |
||||